A comparison of three clinical factors as predictive markers for response to immunotherapy in non-small cell lung cancer.

被引：0
|
作者：
Preeshagul, Isabel Ruth
Sullivan, Kevin M.
Paul, Doru
Maki, Robert G.
Seetharamu, Nagashree
机构：
[1] Northwell Hlth, North Shore Long Isl Jewish, Lake Success, NY USA
[2] North Shore Long Isl Jewish, Lake Success, NY USA
[3] Northwell Hlth, Lake Success, NY USA
[4] Northwell Hlth, Monter Canc Ctr, Lake Success, NY USA
[5] Cold Spring Harbor Lab, Lake Success, NY USA
[6] NYU Med Ctr, New Hyde Pk, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21158
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21158
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical Predictive Markers of Response to Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Rhone, R.
    Raez, L.
    Dumais, K.
    Powery, H.
    Gentile, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1083 - S1083
  • [2] Clinical predictive markers of response to immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.
    Rhone, Raena
    Dumais, Katerine
    Powery, Herman W.
    Gentile, Frank
    Raez, Luis E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Intratumoral heterogeneity as a predictive biomarker in immunotherapy for advanced non-small cell lung cancer.
    Xiao, HaiPing
    Chen, Kai
    Zheng, Yating
    Huang, Mengli
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer
    Genova, Carlo
    Carrega, Paolo
    Distefano, Roberta
    Ottonello, Selene
    Pietra, Gabriella
    Cossu, Irene
    Rijavec, Erika
    Biello, Federica
    Rossi, Giovanni
    Barletta, Giulia
    Dal Bello, Maria Giovanna
    Alama, Angela
    Coco, Simona
    Vanni, Irene
    Maggioni, Claudia
    Merlo, Franco
    Mingari, Maria Cristina
    Grosse, Francesco
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1320 - S1321
  • [5] Galectins role as predictive markers for anti-PD-1-based immunotherapy in non-small cell lung cancer.
    Capalbo, Carlo
    Filetti, Marco
    Scafetta, Giorgia
    Marchetti, Paolo
    Bartolazzi, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [6] Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update
    Blons, Helene
    Garinet, Simon
    Laurent-Puig, Pierre
    Oudart, Jean-Baptiste
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S25 - S36
  • [7] Study on Biomarkers for Predictive the Clinical Efficacy of Non-small Cell Lung Cancer Immunotherapy
    Cui, T.
    Tian, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S613 - S613
  • [8] Predictive molecular markers in non-small cell lung cancer
    Rosell, R
    Tarón, M
    O'Brate, A
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (02) : 101 - 109
  • [9] Immunological markers of outcome of non-small cell lung cancer.
    Potter, DA
    Amin, C
    Mohiuddin, A
    Badve, S
    Davidson, D
    Kesler, K
    Hanna, N
    Edenberg, H
    Einhorn, L
    Mitra, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 678S - 678S
  • [10] A predictive signature for response to immunotherapy in non-small cell lung cancer based on plasma proteomics and clinical parameters
    Shaked, Y.
    Lahav, C.
    Harel, M.
    Jacob, E.
    Sela, I.
    Yahalom, G.
    Elon, Y.
    Sharon, O.
    Kamer, I.
    Dicker, A.
    Bar, J.
    Katzenelson, R.
    Wolf, I.
    Gottfried, M.
    Abu-Amana, M.
    Agbarya, A.
    Nechushtan, H.
    Moskovits, M. T.
    Zer, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S388 - S388
12345